Onxeo SA (0NWK.L)
| Previous close | 0.7305 |
| Open | 0.3720 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.3720 - 0.3720 |
| 52-week range | 0.3720 - 0.3720 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 210,196 |
| Beta (5Y monthly) | 1.19 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Onxeo S.A.: Combined General Meeting of August 17, 2022: Availability of Preparatory Documents and Participation & Voting Procedures
PARIS, July 29, 2022--Regulatory News: Onxeo S.A. (Euronext Growth: ALONX, Nasdaq First North: ONXEO) (Paris:ALONX) (NASDAQ OMX:ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR) in particular against rare or resistant forms of cancer, today announced the availability of the preparatory documents for its Combined General Meeting of August 17, 2022.
- Business Wire
Onxeo Announces a Combined General Meeting on August 17, 2022
PARIS, July 12, 2022--Regulatory News: Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North Copenhagen: ONXEO), hereafter "Onxeo" or the "Company", a clinical-stage biotechnology company specializing in the development of innovative drugs targeting tumor DNA Damage Response (DDR), today announces that it will hold a Combined General Meeting on Wednesday, August 17, 2022 at 2:00 pm CEST at the Renaissance Paris Nobel Tour Eiffel Hotel, 55 avenue Raymond Poincaré, 75116 Paris.
- Business Wire
Summary of ONXEO’s Liquidity Contract with Kepler Cheuvreux
PARIS, July 04, 2022--Regulatory News: Under the liquidity contract entered into between ONXEO (Paris:ALONX) (NASDAQ OMX:ONXEO) and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2021:
